DAta-driven personaLIzation of a digitAl Health Solution to Support Family Caregivers of Children With Chronic Conditions
Latest Information Update: 03 Jun 2025
At a glance
- Drugs Semaglutide (Primary)
- Indications Obesity
- Focus Adverse reactions
- Acronyms DALIA
- Sponsors Adhera Therapeutics
Most Recent Events
- 29 May 2025 Status changed from not yet recruiting to active, no longer recruiting.
- 14 Feb 2025 Planned initiation date changed from 1 Jan 2025 to 1 Mar 2025.
- 26 Nov 2024 Planned number of patients changed from 120 to 40.